Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Other Working Capital Changes (2024 - 2025)

BioAge Labs (BIOA) has disclosed Other Working Capital Changes for 2 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 84.1% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 86.3% year-over-year, with the annual reading at $1.7 million for FY2025, 86.3% down from the prior year.
  • Other Working Capital Changes hit $1.7 million in Q4 2025 for BioAge Labs, down from $2.9 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $10.9 million in Q4 2024 to a low of -$4.1 million in Q2 2025.